Related Experiment Video

Updated: May 28, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

[Linear growth retardation in children under five years of age: a baseline study]

Anete Rissin1, José Natal Figueiroa, Maria Helena D'Aquino Benício

  • 1Departamento de Pesquisas, Instituto de Medicina Integral Prof. Fernando Figueira - IMIP, Rua dos Coelhos, nº 300. 50070-550 Recife PE.arissin@gmail.com

Ciencia & Saude Coletiva
|October 28, 2011
PubMed

Insights

Linear growth retardation in children is linked to multiple factors including income, mother's education, and birth weight. Addressing these social, biological, and healthcare determinants is crucial for child development.

Area of Science:

  • Pediatrics
  • Public Health
  • Child Development

Context:

  • Linear growth retardation, a key indicator of child undernutrition, affects millions globally.
  • Understanding its determinants is vital for effective public health interventions.
  • This study focuses on children under five years old.

Purpose:

  • To determine the prevalence of linear growth retardation (stunting).
  • To analyze factors associated with stunting across socio-economic, residence, sanitary, maternal, biological, and healthcare access domains.
  • To identify modifiable risk factors for targeted interventions.

Summary:

  • A study of 2040 children under five identified significant associations between stunting and variables like income, mother's schooling, birth weight, water supply, and healthcare access.
  • Poisson regression analysis revealed key risk factors, emphasizing the multi-causal nature of growth delay.
  • Positive associations were found with poor housing conditions (roof type, inhabitants per room).

Impact:

  • Identifies critical risk factors for linear growth retardation in young children.
  • Highlights the need for integrated interventions addressing socio-economic, environmental, and healthcare factors.
  • Provides evidence for policymakers to develop targeted strategies to combat childhood stunting.

More Related Videos

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools11:29

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools

Published on: June 20, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...